Telligent Fund LP Makes New $1.57 Million Investment in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Telligent Fund LP bought a new position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) during the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund bought 3,000 shares of the medical equipment provider’s stock, valued at approximately $1,566,000. Intuitive Surgical comprises approximately 1.5% of Telligent Fund LP’s investment portfolio, making the stock its 21st biggest position.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in ISRG. Massachusetts Financial Services Co. MA acquired a new position in shares of Intuitive Surgical during the 3rd quarter valued at about $558,807,000. International Assets Investment Management LLC boosted its position in shares of Intuitive Surgical by 49,383.6% during the 3rd quarter. International Assets Investment Management LLC now owns 1,090,619 shares of the medical equipment provider’s stock valued at $535,788,000 after acquiring an additional 1,088,415 shares during the last quarter. FMR LLC lifted its position in Intuitive Surgical by 8.3% in the third quarter. FMR LLC now owns 10,971,085 shares of the medical equipment provider’s stock valued at $5,389,765,000 after buying an additional 838,793 shares during the last quarter. Wilmington Savings Fund Society FSB lifted its position in Intuitive Surgical by 15,322.2% in the third quarter. Wilmington Savings Fund Society FSB now owns 555,661 shares of the medical equipment provider’s stock valued at $272,980,000 after buying an additional 552,058 shares during the last quarter. Finally, Strategic Financial Concepts LLC lifted its position in Intuitive Surgical by 50,740.8% in the fourth quarter. Strategic Financial Concepts LLC now owns 312,671 shares of the medical equipment provider’s stock valued at $163,202,000 after buying an additional 312,056 shares during the last quarter. Institutional investors and hedge funds own 83.64% of the company’s stock.

Intuitive Surgical Price Performance

ISRG opened at $588.50 on Friday. The stock has a market capitalization of $209.61 billion, a price-to-earnings ratio of 91.81, a price-to-earnings-growth ratio of 5.51 and a beta of 1.39. The business has a 50-day moving average of $553.03 and a two-hundred day moving average of $512.59. Intuitive Surgical, Inc. has a 12 month low of $364.17 and a 12 month high of $616.00.

Insider Buying and Selling at Intuitive Surgical

In other news, CFO Jamie Samath sold 188 shares of the business’s stock in a transaction dated Friday, November 29th. The stock was sold at an average price of $539.00, for a total transaction of $101,332.00. Following the completion of the sale, the chief financial officer now owns 8,757 shares in the company, valued at approximately $4,720,023. The trade was a 2.10 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, EVP Robert Desantis sold 376 shares of the business’s stock in a transaction dated Friday, November 29th. The stock was sold at an average price of $539.00, for a total value of $202,664.00. Following the sale, the executive vice president now owns 5,506 shares of the company’s stock, valued at $2,967,734. The trade was a 6.39 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 5,940 shares of company stock worth $3,333,485 in the last 90 days. 0.80% of the stock is owned by company insiders.

Wall Street Analysts Forecast Growth

ISRG has been the topic of a number of recent analyst reports. Morgan Stanley raised shares of Intuitive Surgical from an “equal weight” rating to an “overweight” rating and upped their target price for the company from $522.00 to $650.00 in a research report on Monday, December 2nd. Citigroup boosted their price target on shares of Intuitive Surgical from $640.00 to $711.00 and gave the stock a “buy” rating in a research note on Friday, January 24th. Barclays boosted their price target on shares of Intuitive Surgical from $610.00 to $674.00 in a research note on Monday, January 27th. Evercore ISI boosted their price target on shares of Intuitive Surgical from $490.00 to $530.00 in a research note on Monday, January 27th. Finally, UBS Group boosted their price target on shares of Intuitive Surgical from $500.00 to $560.00 and gave the stock a “neutral” rating in a research note on Monday, January 27th. One research analyst has rated the stock with a sell rating, five have issued a hold rating and sixteen have given a buy rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $613.10.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.